Kenvue (KVUE) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US49177J1025

Kenvue Inc. (NYSE: KVUE) is a global consumer health company covering three main sectors: Self Care, Skin Health and Beauty, and Essential Health.

In the Self Care branch, Kenvue provides a range of products such as cough, cold, allergy remedies, pain relief medications, digestive health aids, and smoking cessation solutions. Popular brands under this segment include Tylenol, Nicorette, and Zyrtec.

The Skin Health and Beauty division focuses on offering face and body care products, hair care solutions, as well as sun care and other related items. Notable brands featured here are Neutrogena, Aveeno, and OGX.

Lastly, the Essential Health unit caters to oral and baby care, women's health, and wound care essentials. Recognizable products in this category are Listerine, Johnson's, Band-Aid, and Stayfree.

Founded in 2022, Kenvue Inc. is headquartered in Skillman, New Jersey. To learn more about Kenvue Inc. and its offerings, you can visit their website at https://www.kenvue.com.

AI improved, may contain errors or wrong assumptions

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Kenvue (KVUE) - Stock Price & Dividends

KVUE Stock Overview

Market Cap in USD 36,960m
Sector Consumer Defensive
Industry Household & Personal Products
GiC SubIndustry Personal Care Products
TER 0.00%
IPO / Inception 2023-05-04

KVUE Stock Ratings

Fundamental 3.44
Dividend 3.98
Growth 5y -5.51
Rel. Performance vs Sector -2.94
Analysts 3.80
Fair Price Total Ret. 16.55
Fair Price DCF 28.22

KVUE Dividends

Yield 12m 3.17%
Yield on Cost 5y 2.30%
Dividends CAGR 5y 0.00%
Payout Consistency 100.0%

KVUE Growth Ratios

Growth 12m -27.59%
Growth Correlation 12m -60%
Growth Correlation 3m -27%
CAGR 5y -27.59%
CAGR / Mean Drawdown -1.50
Sharpe Ratio 12m -1.41
Alpha vs SP500 12m -34.29
Beta vs SP500 5y weekly 0.06
CAPM 5.37%
Average Daily Range 2m 1.84%
Regime Oscillator 33.45
Volatility GJR Garch 1y 23.50%
Price / SMA 50 -7.39%
Price / SMA 200 -12.77%
Current Volume 15954.2k
Average Volume 20d 17049.5k

External Links for KVUE Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of KVUE stocks?
As of February 28, 2024, the stock is trading at USD 18.92 with a total of 15,954,207 shares traded.
Over the past week, the price has changed by -0.73%, over one month by -8.28%, over three months by -5.18% and over the past year by -27.59%.
Why is KVUE stock down?
Check with which Index or Commodity KVUE has the highest Correlation, do they have a common driver?
Review the Fundamentals to find weaknesses (Debt, low returns). Check the Performance of the Peer-Group to find out, if the entire sector is under pressure.
Period Return KVUE Return S&P 500
1 Month -8.28% 4.00%
3 Months -5.18% 11.99%
12 Months -27.59% 29.39%
What is the forecast for KVUE stock price target?
According to ValueRays Forecast Model, KVUE Kenvue will be worth about 17.9 in February 2025. The stock is currently trading at 18.92. This means that the stock has a potential downside of -5.5%.
Issuer Forecast Upside
Wallstreet Target Price 22.9 21.1%
Analysts Target Price 26.7 41.1%
ValueRay Target Price 17.9 -5.5%